Literature DB >> 9928388

Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells.

K Hildner1, E Märker-Hermann, J F Schlaak, C Becker, T Germann, E Schmitt, K H Meyer zum Büschenfelde, M F Neurath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9928388     DOI： 10.1111/j.1749-6632.1998.tb11129.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.

Authors:  N Van Damme; F De Keyser; P Demetter; D Baeten; H Mielants; G Verbruggen; C Cuvelier; E M Veys; M De Vos
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

Review 2.  Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.

Authors:  Parambir S Dulai; William J Sandborn; Samir Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-27

3.  The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Christabelle M Chen; Harpal K Marway; Sean McKeag; Charles V J Mifsud; Andrew M Pilling; Matthew J Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

4.  Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy.

Authors:  C Cuffari; D Y Li; J Mahoney; Y Barnes; T M Bayless
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

5.  LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.

Authors:  Mark M T J Broekman; Hennie M J Roelofs; Frank Hoentjen; Renske Wiegertjes; Nicole Stoel; Leo A Joosten; Dirk J de Jong; Geert J A Wanten
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients.

Authors:  E Roekevisch; K Szegedi; D P Hack; M E Schram; P C J M Res; J D Bos; M M G Leeflang; R M Luiten; S Kezic; P I Spuls; M A Middelkamp-Hup
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-02-05       Impact factor: 6.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.